The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO Italy 2022 | The importance of using multidisciplinary approaches when treating rare hematological malignancies
Alessandra Romano, MD, PhD, University of Catania, Catania, Italy, discusses the importance of using multidisciplinary approaches when diagnosing and treating patients with Waldenström’s macroglobulinemia (WM), amyloidosis, and systemic mastocytosis (SM), and further highlights the promise of novel immunotherapeutic approaches. This interview took place at the 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.
